1. Home
  2. CFR vs BIO Comparison

CFR vs BIO Comparison

Compare CFR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullen/Frost Bankers Inc.

CFR

Cullen/Frost Bankers Inc.

HOLD

Current Price

$131.16

Market Cap

8.2B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$265.66

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFR
BIO
Founded
1868
1952
Country
United States
United States
Employees
6008
7450
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CFR
BIO
Price
$131.16
$265.66
Analyst Decision
Hold
Strong Buy
Analyst Count
13
4
Target Price
$143.08
$358.50
AVG Volume (30 Days)
517.9K
237.8K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.72
$2.74
Revenue Next Year
$4.70
$3.05
P/E Ratio
$14.55
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$100.31
$211.43
52 Week High
$148.97
$343.12

Technical Indicators

Market Signals
Indicator
CFR
BIO
Relative Strength Index (RSI) 32.55 41.30
Support Level $124.76 $239.33
Resistance Level $132.83 $289.61
Average True Range (ATR) 3.29 7.68
MACD -0.91 0.48
Stochastic Oscillator 15.73 24.82

Price Performance

Historical Comparison
CFR
BIO

About CFR Cullen/Frost Bankers Inc.

Cullen/Frost is a regional US bank with around $53 billion in assets (as of December 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: